Fg. Barker et al., Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system, NEUROSURGER, 49(1), 2001, pp. 15-24
OBJECTIVE: Hemorrhages from cerebral cavernous malformations (CMs) sometime
s seem to occur in closely spaced "clusters" interspersed with long hemorrh
age-free intervals. Clustering of hemorrhages could affect retrospective as
sessments of radiosurgery efficacy in prevention of CM rehemorrhage. Howeve
r, this empirical observation had not been tested quantitatively. To test w
hether CM hemorrhages tend to cluster, we reviewed pretreatment rebleeding
rates after a first symptomatic hemorrhage in CM patients who later underwe
nt surgery or radiosurgery.
METHODS: We performed a retrospective review of 141 patients with CMs who p
resented with clinically overt hemorrhage, and who subsequently underwent s
urgery or proton beam radiosurgery during an 18-year period. Statistical mo
dels were used to analyze all events per person and identify potential vari
ation in rebleeding risk with time after a previous hemorrhage.
RESULTS: Sixty-three of 141 patients experienced a second hemorrhage before
treatment; 16 had additional hemorrhages. Five hundred thirty-eight patien
t years elapsed between first hemorrhages and treatment. The cumulative inc
idence of a second hemorrhage after the first CM hemorrhage was 14% after 1
year and 56% after 5 years. During the first 2.5 years after a hemorrhage,
the monthly rehemorrhage hazard was 2%. The risk then decreased spontaneou
sly to less than 1% per month, which represents a 2.4-fold decline (P < 0.0
01). Rehemorrhage rates were higher in younger patients (P < 0.01), but not
in females or in patients with deep lesions. Shorter intervals between suc
cessive hemorrhages did not predict higher subsequent rehemorrhage risk.
CONCLUSION: The rehemorrhage rate from untreated CMs is high initially, and
it decreases 2 to 3 years after a previous hemorrhage. This hazard pattern
generates the observed temporal clustering of hemorrhages from untreated C
Ms.